Back to overview

Max Planck Innovation Receives IPTEC Award for Excellence in Technology Transfer

Max Planck Innovation GmbH, the technology transfer agency of the Max Planck Society, was honored for outstanding achievement in developing technology transfer and licensing in the public sector. The award was presented yesterday, June 11, during the third International Marketplace and Conference for Technology Transfer Professionals (IPTEC) in Frankfurt.

As in previous years, three winners - one each from the public, academic and private sectors - were selected by the IPTEC's advisory board, comprised of representatives from global corporations, universities and public institutions. The Katholieke Universiteit Leuven and Procter & Gamble were recognized for the university and industry category in 2008. Past winners are NASA, the European Space Agency, Tsinghua University, Stanford University, Thomson and IBM.

“We are honored to be recognized for our commitment to professional technology transfer,” said Jörn Erselius, Managing Director of Max Planck Innovation. “More than 30 years technology transfer for the Max Planck Society clearly show that excellent basic research generates pioneering inventions that can change people’s lives.” Prominent examples of successful technology transfer projects are the FLASH-technology which revolutionized magnetic resonance imaging, the novel cancer treatment Sutent® and the RNA interference technology that is being employed for the investigation of gene function and could also lead to a new class of therapeutics. Overall, Max Planck Innovation has so far managed more than 2,800 inventions, has closed more than 1,700 license agreements and coached numerous spin-off companies.

“But we have also learnt that it takes a lot of patience and perseverance to exploit the economic and social benefits of inventions,” Erselius continues. “It therefore remains a major ambition of our team to work with investors, industry and technology transfer professionals to create new instruments that help overcome the so-called ‘innovation gap’ between early-stage research projects and industrial development.” Most recent examples for such initiatives are Max Planck Innovation’s subsidiaries LDC (Lead Discovery Center) and LSI (Life Science Incubator). While the LDC was set-up as a new approach to advance promising research results into the development of novel drugs, the LSI aims to professionally prepare start-up companies for their seed financing. IPTEC, which takes place in Frankfurt from June 11 - 12, 2008, provides a premier platform for exchanging experience with international technology creators, technology transfer pro fessionals and business developers and learning about the latest trends in the field. In addition, technology presentations will showcase the newest available technologies.


Notes to editors

About Max Planck Innovation

Max Planck Innovation advises and supports scientists of the Max Planck Society in evaluating inventions and filing patent applications. Max Planck Innovation markets patents and technologies to industry and coaches founders of new companies based on research results from Max Planck Institutes.

Every year, Max Planck Innovation evaluates about 150 inventions, of which about half lead to the filing of a patent application. Since 2000, Max Planck Innovation advised more than 35 spin-offs, closed more than 700 license deals and generated proceeds of more than 130 million Euros for inventors, institutes and the Max Planck Society. As a result, Max Planck Innovation is among the world's most successful technology transfer organizations.

Max Planck Innovation was founded in 1970 as Garching Instrumente GmbH and operated under the name of Garching Innovation from 1993 to 2006.


Dr Jörn Erselius, Managing Director Tel: + 49 89 29 09 19-0, Email:

News alert

Do you want to receive our newsletter and press releases?
Subscribe here

Media contact

Markus Berninger
Phone: (089) 290919-30